Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents

Summary

This study evaluates the effect of ecopipam tablets in children and adolescents in the treatment of Tourette's Syndrome (TS). Half of the participants will receive ecopipam tablets, while the other half will receive matching placebo tablets

Timeline

Start

2019-06-28

Primary completion

2021-09-23

Completion

2021-09-23

Outcome

Met primary endpoint

registry analysis (superiority test); Ecopipam HCI 2 mg/kg/Day vs Placebo; p =0.011; Difference in Least Square Mean -3.44 (95% CI -6.09 to -0.79); NCT04007991 ↗

Drugs

Indications